O'Melveny
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Noted for its expertise in guiding leading life sciences and biotechnology companies to the Hong Kong and U.S public markets, O'Melveny is also equipped to handle M&A, IP, licensing and private equity matters. The practice is spearheaded by Beijing-based Ke Geng, reputed for out-licensing transactions, as well as leading pharmaceutical and biotechnology issuers in Hong Kong IPOs. While Ke Zhu and Portia Ku both excel in capital markets transactions.
Legal 500 Editorial commentary
Key clients
- TYK Medicines
- Sunho Biologics